OR | 95% CI | P | |
---|---|---|---|
First step | |||
Midazolam (reference: no midazolam) | 0.720 | 0.128; 4.067 | 0.710 |
Year of enrollment (per year increase) | 0.805 | 0.429; 1.512 | 0.500 |
Propofol (reference: sevoflurane) | 2.653 | 1.395; 5.044 | 0.003 |
ORP (reference: RARP) | 1.061 | 0.583; 1.934 | 0.846 |
Age (per year increase) | 1.098 | 1.046; 1.152 | < 0.001 |
ASA physical status (reference: ASA III) | |||
ASA I | 0.907 | 0.499; 1.649 | 0.749 |
ASA II | 1.286 | 0.595; 2.778 | 0.523 |
Estimated blood loss (per ml increase) | 1.165 | 0.828; 1.638 | 0.381 |
Duration of surgery (per min increase) | 2.028 | 0.657; 6.260 | 0.219 |
Sufentanil (per μg kg−1 h−1 increase) | 1.014 | 1.002; 1.025 | 0.018 |
Final step | |||
Midazolam (reference: no midazolam) | 0.847 | 0.164; 4.367 | 0.842 |
Year of enrollment (per year increase) | 0.829 | 0.458; 1.499 | 0.535 |
Propofol (reference: sevoflurane) | 2.805 | 1.497; 5.256 | 0.001 |
Age (per year increase) | 1.102 | 1.050; 1.156 | < 0.001 |
Sufentanil (per μg kg−1 h−1 increase) | 1.014 | 1.005; 1.024 | 0.004 |